FDA alerted on abort drug

Share this article:
The FDA says it is investigating two more US deaths associated with the medical abortion drug Mifeprex (mifepristone) that were recently reported to the agency by the manufacturer, Danco Laboratories. The FDA has only received verbal notification about the deaths, it says, adding that “we are investigating all circumstances associated with these cases and are not able to confirm the causes of death.”

Last year, an FDA alert confirmed four previous deaths from sepsis that occurred between 2003 and 2005. All four cases tested positive for Clostridium sordellii and involved an off-label dosing regimen.
Concerned Women for America is calling on the FDA to pull Mifeprex from the market, saying it “has pulled other drugs that have caused fewer deaths and less severe complications. ... Why the double standard for an abortion drug that is now linked to the deaths of seven healthy women and over 800 other reported complications?”

The conservative advocacy group said the FDA pulled the imaging agent NeutroSpec after it was linked to two deaths, 20 severe reactions and 46 other less severe reactions. 
Share this article:
close

Next Article in Features

Email Newsletters

More in Features

Read the complete April 2014 Digital Edition

Read the complete April 2014 Digital Edition

Click the above link to access the complete Digital Edition of the April 2014 issue of MM&M, with all text, charts and pictures.

Antidote: Are e-cigarettes safe?

Antidote: Are e-cigarettes safe?

The pros and cons of e-cigarettes

Combating concept churn

Combating concept churn

There's no cure. But the good news is that prophylaxis is possible.